Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,108.40
(
0.00%
)
US TECH 100
26,362.40
(
1.17%
)
Dow Jones
49,310.32
(
0.00%
)
Brent Oil
99.76
(
-1.43%
)
Bitcoin
78,372.23
(
0.12%
)
News Focus
News Focus
Post# of 257442
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122884
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 245554

Tuesday, 02/21/2023 12:28:50 PM

Tuesday, February 21, 2023 12:28:50 PM

Post# of 257442
APLS up only 12% on FDA approval of Syfovre (announced after the close on Friday). The modest advance is rational, IMO, because Syfovre simply isn’t that great.

On APLS’ CC Friday evening, executives were touting Syfovre as the one of the greatest breakthroughs in ophthalmology, ever, which I found to be a pretty big turnoff. Please see #msg-171243138 for related info.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today